Morgan Stanley’s Achilles Therapeutics plc American Depositary Shares ACHL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-33,731
| Closed | -$38.5K | – | 8277 |
|
|
2024
Q4 | $38.5K | Buy |
33,731
+17,300
| +105% | +$19.7K | ﹤0.01% | 6369 |
|
|
2024
Q3 | $16.8K | Buy |
16,431
+7,500
| +84% | +$7.65K | ﹤0.01% | 6552 |
|
|
2024
Q2 | $7.28K | Sell |
8,931
-9,270
| -51% | -$7.56K | ﹤0.01% | 6763 |
|
|
2024
Q1 | $22.8K | Buy |
18,201
+18,161
| +45,403% | +$22.7K | ﹤0.01% | 6450 |
|
|
2023
Q4 | $36 | Sell |
40
-49,980
| -100% | -$45K | ﹤0.01% | 7717 |
|
|
2023
Q3 | $45.5K | Sell |
50,020
-22,733
| -31% | -$20.7K | ﹤0.01% | 6201 |
|
|
2023
Q2 | $68.8K | Sell |
72,753
-210,906
| -74% | -$199K | ﹤0.01% | 6091 |
|
|
2023
Q1 | $272K | Buy |
+283,659
| New | +$272K | ﹤0.01% | 5565 |
|
|
2022
Q4 | – | Sell |
-7,155
| Closed | -$16K | – | 7985 |
|
|
2022
Q3 | $16K | Buy |
7,155
+819
| +13% | +$1.83K | ﹤0.01% | 6900 |
|
|
2022
Q2 | $16K | Buy |
6,336
+115
| +2% | +$290 | ﹤0.01% | 7080 |
|
|
2022
Q1 | $18K | Sell |
6,221
-128
| -2% | -$370 | ﹤0.01% | 7198 |
|
|
2021
Q4 | $32K | Buy |
+6,349
| New | +$32K | ﹤0.01% | 7013 |
|